Business Trip
A podcast by Greg Kubin & Matias Serebrinsky - Joi
59 Episoade
-
Holy poop! Mental health and the gut (part 2 with Bloom Science)
Publicat: 28.09.2023 -
Holy poop! Mental health and the gut (part 1 with Holobiome)
Publicat: 14.09.2023 -
Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)
Publicat: 24.08.2023 -
Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)
Publicat: 17.08.2023 -
The Startup Landscape for Expanding Consciousness
Publicat: 09.08.2023 -
Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)
Publicat: 20.07.2023 -
Live from Psychedelic Science 2023
Publicat: 07.07.2023 -
What VCs Look for in Psychedelic Companies
Publicat: 09.06.2023 -
Developing Non-Hallucinogenic Psychedelics: Bryan Roth
Publicat: 15.05.2023 -
Behind the Scenes of PsyMed Ventures
Publicat: 14.04.2023 -
The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
Publicat: 27.02.2023 -
The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
Publicat: 18.01.2023 -
The quest to improve MDMA
Publicat: 20.12.2022 -
Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment
Publicat: 29.11.2022 -
Perspectives from Christian Angermayer, investor and founder in psychedelics
Publicat: 27.10.2022 -
Soltara: an ethical and profitable ayahuasca retreat
Publicat: 14.09.2022 -
Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics
Publicat: 16.08.2022 -
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti
Publicat: 10.08.2022 -
Microdosing (part 1): James Fadiman and the fundamentals of microdosing
Publicat: 03.08.2022 -
How the DEA and FDA will regulate psychedelic medicine
Publicat: 24.06.2022
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
